Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.8850
+0.0250 (2.91%)
At close: May 15, 2026, 4:00 PM EDT
0.9200
+0.0350 (3.95%)
After-hours: May 15, 2026, 4:17 PM EDT
Company Description
Alps Group Inc, a biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies. The company is based in Kuala Lumpur, Malaysia.
Alps Group Inc
| Country | Malaysia |
| Founded | 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 93 |
| CEO | Seng Tham |
Contact Details
Address: Icon Tower (East), Unit E-18-01 & E-18-02, Level 18 Kuala Lumpur, 50400 Malaysia | |
| Phone | 60 3 2163 1113 |
| Website | alps-holdings.com |
Stock Details
| Ticker Symbol | ALPS |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 2025774 |
| CUSIP Number | G0231P108 |
| ISIN Number | KYG0231P1081 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Seng Tham | Chief Executive Officer |
| Lye-Ping Cheing | Chief Financial Officer |
| Low Sim | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2026 | 6-K | Report of foreign issuer |
| Feb 23, 2026 | 6-K | Report of foreign issuer |
| Feb 5, 2026 | 6-K | Report of foreign issuer |
| Jan 30, 2026 | 6-K | Report of foreign issuer |
| Jan 21, 2026 | 424B3 | Prospectus |
| Jan 20, 2026 | EFFECT | Notice of Effectiveness |
| Jan 14, 2026 | UPLOAD | Filing |
| Jan 8, 2026 | 6-K | Report of foreign issuer |
| Jan 7, 2026 | F-1 | Registration statement for certain foreign private issuers |
| Nov 12, 2025 | SCHEDULE 13D | Filing |